Modulators of exchange proteins directly activated by cAMP (EPACS)

Pharmaceutical composition comprising omega-(arylsulfonyl)alkylnitrile

Formulation Solution Adapted to Prolong Plasma Times of Drugs in Mammals Including Humans

METHODS OF TREATING AND PREVENTING ENDOTHELIAL DYSFUNCTION USING BARDOXOLONE METHYL OR ANALOGS THEREOF

Ternary pesticidal mixtures

Compositions and methods for treating otitis media and other conditions with inhibitors of CYLD

CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA

Kinase inhibitors for the treatment of cancer

Pharmaceutical compounds

PHARMACEUTICAL COMPOSITION FOR TREATING DISORDERS ASSOCIATED WITH INSULIN RESISTANCE

Aryl substituted propenoic amides and esters

Agents for the control of parasites on animals

Substituted phenylcarbamoyl alkylamino arene compounds and N,N′-BIS-arylurea compounds

Treatment of circadian rhythm disorders

Compounds for treating proliferative disorders

METHODS OF USING ESTROGEN RECEPTOR-BETA LIGANDS AS RADIATION MITIGATORS

Substitute diphenylamine compounds use thereof as antitumor agents

Therapeutic curcumin derivatives

Small molecule xanthine oxidase inhibitors and methods of use

Intranasal formulation of epinephrine for the treatment of anaphylaxis

Compositions for increasing hair growth

Small molecule xanthine oxidase inhibitors and methods of use

Small molecule xanthine oxidase inhibitors and methods of use

Small molecule xanthine oxidase inhibitors and methods of use

METHODS FOR USING SYNTHETIC TRITERPENOIDS IN THE TREATMENT OF BONE OR CARTILAGE DISEASES OR CONDITIONS

Aniline derivatives, their preparation and their therapeutic application

Modulators of ATP-binding cassette transporters

Methods of inhibiting xanthine oxidase activity in a cell

Small molecule xanthine oxidase inhibitors and methods of use

Compounds for treatment of cell proliferative diseases

COMBINATION TREATMENT OF CANCER

METHODS OF INDUCING CHONDROGENESIS IN MESENCHYMAL STEM CELLS USING SYNTHETIC TRITERPENOIDS

METHODS FOR REDUCING THE RISK OF CONVERSION TO CLINICALLY DEFINITE MULTIPLE SCLEROSIS

METHODS AND FORMULATIONS OF TREATING THROMBOSIS WITH BETRIXABAN AND A P-GLYCOPROTEIN INHIBITOR

Drug delivery system for sustained delivery of bioactive agents

Polymorphs of CDDO ethyl ester and uses thereof

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Bicyclic aryl sphingosine 1-phosphate analogs

METHOD FOR REGULATING SKIN PIGMENTATION

USE OF PHOSPHODIESTERASE INHIBITORS FOR TREATING MULTIDRUG RESISTANCE

Catechol diethers as potent anti-HIV agents

Therapeutic compounds and methods of use

Compounds and methods for inducing chondrogenesis

Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors

Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients

Methods for Treating Osteoarthritis

Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones

Continuous administration of dopa decarboxylase inhibitors and compositions for same

Continuous administration of dopa decarboxylase inhibitors and compositions for same

Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same

Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same

Use of aminoacetonitrile derivatives against endoparasites

Delayed release, oral dosage compositions that contain amorphous CDDO-Me

Pharmaceutical compositions comprising entacapone, levodopa, and carbidopa

Small Molecule CD38 Inhibitors and Methods of Using Same

USE OF INORGANIC MATRIX AND ORGANIC POLYMER COMBINATIONS FOR PREPARING STABLE AMORPHOUS DISPERSIONS

Chromenone derivatives

Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability

Palatable suspending vehicle for pharmaceutical ingredients

COMPOSITION FOR INHIBITION OF CATHEPSIN K

Methods of treating hemoglobinopathies

Pesticidal compositions and processes related thereto

Small molecule xanthine oxidase inhibitors and methods of use

INHIBITORS OF EYA2

Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

Entacapone for prevention and treatment of atherosclerosis

Functionalized magnetic nanoparticles and use in imaging amyloid deposits and neurofibrillary tangles

Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma

TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS

Selective androgen receptor modulator for treating hormone-related conditions

Pharmaceutical composition for treating ischemic events

Methods of using derivatives of (−)-venlafaxine

Thiol mediated/activated prodrugs of sulfur dioxide (SO) having anti-bacterial activity

COMPOSITION OF ENTACOPONE

ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

Anti-cancer lead molecule

Methods for treating prostate cancer

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

Pesticidal Active Mixtures Comprising Isoxazoline Compounds I

Inhibition of Post-Radiation Tumor Growth

Crush resistant delayed-release dosage forms

Methods of treating muscular dystrophy

JAK/STAT INHIBITORS AND MAPK/ERK INHIBITORS FOR RSV INFECTION

NOVEL USE OF BENZOFURANYLSULFONATES

Method of treating hypertension disorder and a pharmaceutical agent

Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-O-methyl transferase inhibitors and compositions for same

PRAMIPEXOLE TRANSDERMAL DELIVERY FOR SEVERE HEADACHES

METHODS FOR TREATMENT OF MELANOMA

Method for treating malaria

Inhibitors of the influenza A virus M2 proton channel

PESTICIDAL MIXTURES

SELECTIVE ANDROGEN RECEPTOR MODULATORS

Synthetic triterpenoids and methods of use in the treatment of disease

Combination Treatment with VEGF-C Antagonists

Compositions for transdermal delivery of active agents

3-acyl-ingenols II

Methods for preventing flea allergy dermatitis in companion animals

Ophthalmic solution for absorbing ultraviolet radiation and method for absorbing ultraviolet radiation

Cathepsin cysteine protease inhibitors

PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN

Indanyloxyphenylcyclopropanecarboxylic acids

COMPOSITIONS AND USES

Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof

ORAL DOSAGE FORM

Method of inhibiting ABCG2 and other treatment methods

Use of leflunomide and malononitrilamides

PHARMACEUTICAL COMPOSITIONS TO TREAT FIBROSIS

METHOD FOR TREATMENT OF SORES IN THE ORAL CAVITY WITH A COMPOSITION CONTAINING ULTRAVIOLET LIGHT-ABSORBING INGREDIENTS

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses

ACTIVATING PHOSPHORYLATION SITE ON GLUTAMINASE C

Compounds and Methods for Treating Pain

6,7-DIHYDRO-5H-BENZO[7]ANNULENE DERIVATIVES, PROCESS FOR PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS COMPRISING THEM, AND THE USE THEREOF FOR PRODUCTION OF MEDICAMENTS

Nitrile derivatives and their pharmaceutical use and compositions

Cysteine protease inhibitors for the treatment of parasitic diseases

Aryloxyurea compound and pest control agent

SPOT-ON PESTICIDE COMPOSITION CONTAINING A PYRETHROID AND MACROCYCLIC LACTONE

Mast cell stabilizers in the treatment of obesity

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Treatment of prostate carcinoma

Stat5b transgenic mice and methods of use thereof

METHOD AND COMPOSITION FOR TREATING A DISEASE OR CONDITION RELATED TO OREXIN RECEPTOR 1, OREXIN RECEPTOR 2, SOMATOSTATIN RECEPTOR 2 OR DOPAMINE D2L RECEPTOR

Topical therapeutic formulations

USE OF TERIFLUNOMIDE FOR TREATING MULTIPLE SCLEROSIS

Sulfonamide compounds for inhibition of metastatic tumor growth

Compositions and methods for treating skin cancer associated diseases

Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use

Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans

N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Substituted triazolopyridines

USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS

Phenylthioacetate compounds, compositions and methods of use

DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERS

USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE

INTERFERON THERAPIES IN COMBINATION WITH BLOCKADE OF STAT3 ACTIVATION

METHOD OF TREATING A VIRAL INFECTION DYSFUNCTION BY DISRUPTING AN ADENOSINE RECEPTOR PATHWAY

PHARMACEUTICAL COMPOSITIONS OF SELECTIVE ANDROGEN RECEPTOR MODULATORS AND METHODS OF USE THEREOF

SYNTHETIC TRITERPENOIDS AND TRICYCLIC-BIS-ENONES FOR USE IN STIMULATING BONE AND CARTILAGE GROWTH

DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF NEURALLY MEDIATED HYPOTENSION

Arylamide derivatives having antiandrogenic properties

Acyl sulfonamide compounds

Mitochondria and human immunodefiency virus type 1

HETEROARYL IMIDAZOLONE DERIVATIVES AS JAK INHIBITORS

Substituted phenylcarbamoyl alkylamino arene compounds and N,N'-BIS-arylurea compounds

Tyrosine kinase inhibitors as anti-kinetoplastid agents

Compositions and methods for the treatment of asthma and associated disorders

ENDOPARASITICIDAL COMPOSITIONS

Compositions and methods for enhancing bioenergetic status in female germ cells

Isoform of bruton's tyrosine kinase (BTK) protein

ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN

NEW ISOFORM OF BRUTON'S TYROSINE KINASE (BTK) PROTEIN

Modulators of ATP-binding cassette transporters

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS

SELECTIVE ANDROGEN RECEPTOR MODULATORS FOR TREATING DIABETES

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

SUSTAINED RELEASE ORAL MATRIX AND METHODS OF MAKING THEREOF

CYTOTOXIC THERAPY BY PROTON FLUX MODULATION

USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS

CATHEPSIN INHIBITORS FOR TREATING MICROGLIA-MEDIATED NEURON LOSS IN THE CENTRAL NERVOUS SYSTEM

Methods of reducing virulence in bacteria

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

Ion-Channel Regulator Compositions and Methods of Using Same

INTERFERON-INDUCING COMPOUNDS AND USES THEREOF

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTEROIDS

Method of treating actinic keratosis and basal cell carcinoma

METHOD FOR THE TREATMENT OF CANCER

ORAL DOSAGE FORM

Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases

Method for treating osteoarthritis

Pharmaceutical composition for treating parkinson's disease and preparation method thereof

Treatment for Amyotrophic Lateral Sclerosis

Use of phosphodiesterase inhibitors for treating multidrug resistance

Co-administration of an agent linked to an internalization peptide with an anti-inflammatory

Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker

USE OF THE COMBINATION OF TERIFLUNOMIDE AND GLATIRAMER ACETATE FOR TREATING MULTIPLE SCLEROSIS

Methods of using derivatives of (−)-venlafaxine

Single unit oral dose pharmaceutical composition comprising levodopa, carbidopa and entacapone or salts thereof

Synthetic triterpenoids and methods of use in the treatment of disease

Compounds for treatment of cell proliferative diseases

(Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability

COMBINATION TREATMENT WITH VEGF-C ANTAGONISTS

METHOD OF TREATING BIPOLAR DISORDER OR DEPRESSION USING AN ANTIESTROGEN

Pellets Formulation

Topical Compositions Comprising An Alkoxylated Diphenylacrylate Compound And An Organic Nonionic Emulsifier

Treatment for multiple sclerosis

Bicyclic aryl sphingosine 1-phosphate analogs

Pharmaceutical composition for treating ischemic events

Nitrile derivatives and their pharmaceutical use and compositions

Composition comprising hepatic therapeutic active for treating liver diseases, certain cancers and liver health maintenance

PERMANENTLY CHARGED SODIUM AND CALCIUM CHANNEL BLOCKERS AS ANTI- INFLAMMATORY AGENTS

(Z)-2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID-(4'-TRIFLUOROMETHYLPHENYL)-AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY

Targeting EN2, PAX2, and/or DEFB1 for treatment of prostate conditions

Palatable suspending vehicle for pharmaceutical ingredients

4-(phenoxyalkyl)thio)-phenoxyacetic acids and analogs

USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS

Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use

METHODS AND FORMULATIONS OF TREATING THROMBOSIS WITH BETRIXABAN AND A P-GLYCOPROTEIN INHIBITOR

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

NOVEL PROTEIN KINASE MODULATORS AND THERAPEUTIC USES THEREOF

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTERIODS

-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING CANCER AND METHODS FOR PREDICTING A RESPONSE TO SUCH TREATMENTS

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS

Inhibitors of the influenza A virus M2 proton channel

Delayed release, oral dosage compositions that contain amorphous CDDO-Me

Targeting of Histone Deacetylase 2, Protein Kinase CK2, and Nuclear Factor NRF2 For Treatment of Inflammatory Diseases

USING HEAT SHOCK PROTEINS TO IMPROVE THE THERAPEUTIC BENEFIT OF A NON-VACCINE TREATMENT MODALITY

Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality

TREATING VARIOUS DISORDERS WITH CATECHOL-O-METHYL-TRANSFERASE INHIBITORS

DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF MOOD DISORDERS, SLEEP DISORDERS, OR ATTENTION DEFICIT DISORDERS

METHODS FOR REDUCING THE RISK OF AN ADVERSE DRONEDARONE / CALCIUM CHANNEL BLOCKERS INTERACTION IN A PATIENT SUFFERING FROM ATRIAL FIBRILATION

Treating impulse control disorders with catechol-O-methyl-transferase inhibitors

Phenylcyclopropylamine derivatives and their medical use

Substituted 5,6-dihydro-4H-thiazolo[4,5-E]indazoles and their use as positive allosteric modulators of metabotropic glutamate receptors

Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions

Methods for Reducing Platelet Activation and for the Treatment of Thrombotic Events

COMPOSITIONS AND METHODS FOR INHIBITING NF-KB MEDIATED TUMORIGENICITY AND ADHESION-DEPENDENT SURVIVAL OF CANCER CELLS

(R)-2-(3,4-DIMETHOXYPHENOL)-2-ISOPROPYL-6-AZAHEPTANITRIL FORMULAITONS, ANDTHE USE OF SUCH FORMULATIONS IN THE TREATMENT OF CONDITIONS MEDIATED BY THE SEROTONIN TRANSPORTER

Bis(thio-hydrazide amide) formulation

Photochemical internalisation of kinase inhibitors

PROSTATE CANCER PROGRESSION INHIBITOR AND PROGRESSION INHIBITION METHOD

Methods of treating obesity using antioxidant inflammation modulators

METHODS OF TREATING DERMATOLOGIC, GYNECOLOGIC, AND GENITAL DISORDERS WITH CAFFEIC ACID ANALOGS

Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

Continuous administration of dopa decarboxylase inhibitors and compositions for same

Solid forms of selective androgen receptor modulators

DROXIDOPA AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF FIBROMYALGIA

Modulation of axon degeneration

Estrogen receptor ligand and/or interferon beta treatment for neurodegenerative diseases

Phosphodiesterase type III (PDE III) inhibitors or CA-sensitizing agents for the treatment of hypertrophic cardiomyopathy

Methods of using diacerein as an adjunctive therapy for diabetes

SELECTIVE ANDROGEN RECEPTOR MODULATORS FOR TREATING DIABETES

DIRECT DRUG DELIVERY SYSTEM BASED ON THERMALLY RESPONSIVE BIOPOLYMERS

Pharmaceutical compositions for treatment of Parkinsons disease

ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP

Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof

Extended release pharmaceutical composition of entacapone or salts thereof

Temporally-Controlled Treatment of Joint Disease

Compositions, Methods and Kits Useful for Treating a Respiratory Symptom

METHOD OF INHIBITING REMNANT LIPOPROTEIN PRODUCTION

Severe sepsis preventive therapeutic agent

Methods of treating meibomian gland dysfunction

Catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition

NANOPARTICULATE BICALUTAMIDE FORMULATIONS

Inhibition of filovirus entry into cells and uses thereof

Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

Pestcidal active mixtures comprising isoxazoline compounds I

Inhibition of JAK2 as a treatment of pulmonary arterial hypertension

NRF2 SCREENING ASSAYS AND RELATED METHODS AND COMPOSITIONS

Methods of Treating Hepatitis C Virus Infection

PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS

CARBAMIC ACID COMPOUNDS COMPRISING AN AMIDE LINKAGE AS HDAC INHIBITORS

Chromenone derivatives

Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability

Compositions and methods for treating neurodegenerating diseases

Method for administering homeopathically potentiated antibodies against mediator of inflammation

Methods for treating osteoarthritis

Methods of inhibiting tumor cell proliferation

(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseases

N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors

Induction of thyroid iodide-handling gene expression in human cancers

Use of electrophilic compounds for inducing platelet production or maintaining platelet function

Compounds for treatment of cell proliferative diseases

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND CORTICOSTERIODS

COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS

Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer

Tyrosine kinase inhibitors as anti-kinetoplastid agents

Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs

CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASE

Continuous administration of dopa decarboxylase inhibitors and compositions for same

Continuous administration of dopa decarboxylase inhibitors and compositions for same

Nitrile derivatives and their pharmaceutical use and compositions

PROP-2-YN-1-AMINE INHIBITORS OF MONOAMINE OXIDASE TYPE B

METHODS AND APPARATUS FOR TREATING THE PROSTATE

Treating benign prostate hyperplasia with SARMS

Paclitaxel enhancer compounds

COMBINATIONS OF JAK INHIBITORS

Collecting ovarian cancer stem cells from ovarian cancer cells

Aqueous ophthalmic compositions containing anionic therapeutic agents

Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

BIS(THIO-HYDRAZIDE AMIDE) FORMULATION

Carbamic acid compounds comprising an amide linkage as HDAC inhibitors

Tetrahydronaphthalen-2-ol derivatives

Fluorene compound and pharmaceutical use thereof

Method of treating disorders of the cardiovascular system and a pharmaceutical agent

Composition for regenerative treatment of cartilage disease

PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-BETA PROTEIN ACCUMULATION

Method of treating a pathological syndrome and a pharmaceutical agent

GRANULATES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL PRODUCTS CONTAINING THEM

Method of treating a disorder or condition of viral etiology

Biphenylcarboxamide derivatives as hedgehod pathway modulators

SHORT ACTING PHENYLALKYLAMINE CALCIUM CHANNEL BLOCKERS AND USES THEREOF

ABUSE RESISTANT MELT EXTRUDED FORMULATION HAVING REDUCED ALCOHOL INTERACTION